Poxel SA (France) Today
| POXEL Stock | EUR 0.23 0.01 4.17% |
Performance0 of 100
| Odds Of DistressLess than 46
|
Poxel SA is selling at 0.23 as of the 24th of November 2024; that is 4.17% down since the beginning of the trading day. The stock's last reported lowest price was 0.22. Poxel SA has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Poxel SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. The company was founded in 2009 and is headquartered in Lyon, France. Poxel SA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. The company has 30.83 M outstanding shares. More on Poxel SA
Moving together with Poxel Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Poxel Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Poxel SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Poxel SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Poxel SA (POXEL) is traded on Euronext Paris in France and employs 55 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Poxel SA's market, we take the total number of its shares issued and multiply it by Poxel SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Poxel SA operates under Biotechnology sector and is part of Health Care industry. The entity has 30.83 M outstanding shares.
Poxel SA has accumulated about 3.53 M in cash with (16.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Poxel SA Probability Of Bankruptcy
Ownership AllocationPoxel SA owns a total of 30.83 Million outstanding shares. Poxel SA holds 9.84 pct. of its outstanding shares held by insiders and 23.08 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Poxel Ownership Details
Poxel SA Risk Profiles
Although Poxel SA's alpha and beta are two of the key measurements used to evaluate Poxel SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.85 | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.44 | |||
| Risk Adjusted Performance | (0.21) |
Poxel Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Poxel SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Poxel SA Corporate Management
Elected by the shareholders, the Poxel SA's board of directors comprises two types of representatives: Poxel SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Poxel. The board's role is to monitor Poxel SA's management team and ensure that shareholders' interests are well served. Poxel SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Poxel SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Quentin Durand | Chief VP | Profile | |
| Bolze PharmD | COO CoFounder | Profile | |
| Sylvie Bertrand | VP HR | Profile | |
| Pascale MD | CoFounder Affairs | Profile | |
| Noah MBA | Exec Operations | Profile | |
| Sophie HallakouBozec | CoFounder Communication | Profile | |
| Elizabeth MBA | Corp Relations | Profile |
Additional Tools for Poxel Stock Analysis
When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.